What would Brexit mean for UK clinical research?
The EU's flawed Clinical Trials Directive has been held up as a reason why UK research would be better off outside of Europe. With regulatory reform on the way and...
Focus:
Analysis
-
![What would Brexit mean for UK clinical research?]()
-
![Pharma Technology Focus – Issue 44]()
Pharma Technology Focus – Issue 44
In this issue: Clinical trials in Russia, how understanding the microbiome could help with drug delivery, making the most of data analytics, the potential of wearable trackers in clinical trial...
-
![Sick, dying and on a placebo: could we do away with it altogether?]()
Sick, dying and on a placebo: could we do away with it altogether?
Fear about receiving the placebo is one of the biggest barriers to clinical trial recruitment but with new trial set-ups already being investigated to reduce the number of patients in...
-
![January’s top stories: Zika virus, Shire acquired Baxalta]()
January’s top stories: Zika virus, Shire acquired Baxalta
Zika virus was expected to infect four million people in Americas, Shire agreed to acquire Baxalta $32bn, UK's NICE approved AstraZeneca's new ovarian cancer drug Lynparza. Pharmaceutical-technology.com wraps up the...
-
![A matter of trust: online pharmacies and patient data]()
A matter of trust: online pharmacies and patient data
The internet is changing the way prescription medicines are sold and distributed – a more convenient system for the 21st century. But in light of a recent ruling against UK-based...
-
![Pharma Technology Focus – Issue 43]()
Pharma Technology Focus – Issue 43
In this issue: A look inside China’s pharmaceutical market, GSK’s pipeline to 2020, tackling the world’s most pressing clinical needs, new digital tools for clinical trials, a new approach to...
-
![The telling telomere: working towards cancer prediction]()
The telling telomere: working towards cancer prediction
Scientists at Northwestern University and Harvard have achieved a breakthrough in telomere research, raising the prospect of a cancer-predicting blood test. How could the discovery of a vital long-term telomere...
-
![Zeroing in on variability: innovations in asthma treatment]()
Zeroing in on variability: innovations in asthma treatment
Asthma therapies represent a highly active area of drug development, with more than 250 asthma-related products currently in the pipeline. As the variability of the disease becomes clearer, major sources...
-
![The little pink pill: sexual breakthrough for women or barely beneficial?]()
The little pink pill: sexual breakthrough for women or barely beneficial?
Earlier this year the FDA approved the first drug for sexual desire disorder in women, which has since become widely known as ‘the female Viagra’. But does this mark the...
-
![2015: The year’s biggest Pharmaceutical Technology stories]()
2015: The year’s biggest Pharmaceutical Technology stories
Pfizer acquired Allergan for $160bn, Teva bought Allergan Generics, and Salix accepted Valeant's offer. Pharmaceutical-technology.com wraps up the key headlines from 2015.
